HIV-HCV Coinfection and HIV-HBV Coinfection

Assessment of Liver Fibrosis by Non-invasive Techniques

The Role of Genetics and Immune Response in Controlling HCV Infection

In HCV Genotype 1 Patients with Low Viral Load, Pegasys Plus Ribavirin Produces an SVR Rate Similar to That in Genotype 2/3 pts with Low or High Viral Load

Sexual-related Outbreaks of Acute HCV Infection  in HIV Positive Gay Men

The Impact of HAART on Treatment of HIV-HCV and HIV-HBV Coinfection

Is Combination Therapy More Effective Than Monotherapy for Chronic HBV in HIV-coinfected Patients?

Low Incidence of Resistance to Entecavir after 48 Weeks of Treatment in HIV-HBV Coinfected Patients

Survival Outcomes among HIV-HBV Coinfected Patients on HAART

How Common Is Occult HBV Infection in HIV Coinfected Patients?

HBV Vaccination in HIV Patients

Hepatitis Delta Virus Worsens the Outcome of HBV-HIV Coinfected Patients

4-year Outcome of Liver Transplantation in HIV Patients

Treatment of Hepatitis C in HIV-coinfected Patients: Towards an Individualized Approach  

Barriers to Treating HCV in HIV-coinfected Patients

Liver Fibrosis Rates Are High among HIV-monoinfected, HIV-HBV- and HIV-HCV-coinfected Patients

Noninvasive Markers Appear Useful in Predicting Fibrosis in HIV-HCV Coinfected Patients

Limited Impact of Antiretroviral Therapy on Risk of Liver-related Death: The D:A:D Study